BIOMAT Database Logo BIOMAT Database Logo

Current update on medullary thyroid carcinoma. 2013

Dhakshinamoorthy Ganeshan, and Erik Paulson, and Cihan Duran, and Maria E Cabanillas, and Naifa L Busaidy, and Chusilp Charnsangavej
1 Department of Diagnostic Imaging, Unit 1473, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-4009.

OBJECTIVE This article will review the multimodality imaging spectrum of medullary thyroid carcinoma (MTC) with an emphasis on anatomic and functional imaging. Recent advances in the molecular cytogenetics of this tumor and the impact on diagnosis, prognosis, and development of novel targeted therapy will be discussed. CONCLUSIONS MTC is a neuroendocrine tumor with unique clinicopathologic and radiologic features compared with other thyroid malignancies. Imaging plays an important role in the optimal management of this malignancy.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D003952 Diagnostic Imaging Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy. Imaging, Diagnostic,Imaging, Medical,Medical Imaging
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D018276 Carcinoma, Medullary A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992) Carcinomas, Medullary,Medullary Carcinoma,Medullary Carcinomas

Related Publications

Dhakshinamoorthy Ganeshan, and Erik Paulson, and Cihan Duran, and Maria E Cabanillas, and Naifa L Busaidy, and Chusilp Charnsangavej
Medullary Thyroid Carcinoma: An Update on Imaging.
January 2019, Journal of thyroid research,
Dhakshinamoorthy Ganeshan, and Erik Paulson, and Cihan Duran, and Maria E Cabanillas, and Naifa L Busaidy, and Chusilp Charnsangavej
Treatment of medullary thyroid carcinoma: an update.
June 2001, Endocrine-related cancer,
Dhakshinamoorthy Ganeshan, and Erik Paulson, and Cihan Duran, and Maria E Cabanillas, and Naifa L Busaidy, and Chusilp Charnsangavej
Familial non-medullary thyroid carcinoma: an update.
January 2008, Endocrine pathology,
Dhakshinamoorthy Ganeshan, and Erik Paulson, and Cihan Duran, and Maria E Cabanillas, and Naifa L Busaidy, and Chusilp Charnsangavej
[Medullary thyroid carcinoma: current clinical progress].
November 2021, Deutsche medizinische Wochenschrift (1946),
Dhakshinamoorthy Ganeshan, and Erik Paulson, and Cihan Duran, and Maria E Cabanillas, and Naifa L Busaidy, and Chusilp Charnsangavej
[Medullary thyroid carcinoma: current clinical progress].
November 2021, Deutsche medizinische Wochenschrift (1946),
Dhakshinamoorthy Ganeshan, and Erik Paulson, and Cihan Duran, and Maria E Cabanillas, and Naifa L Busaidy, and Chusilp Charnsangavej
Update on medullary thyroid cancer.
June 2014, Endocrinology and metabolism clinics of North America,
Dhakshinamoorthy Ganeshan, and Erik Paulson, and Cihan Duran, and Maria E Cabanillas, and Naifa L Busaidy, and Chusilp Charnsangavej
Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine.
July 2023, Seminars in nuclear medicine,
Dhakshinamoorthy Ganeshan, and Erik Paulson, and Cihan Duran, and Maria E Cabanillas, and Naifa L Busaidy, and Chusilp Charnsangavej
Medullary thyroid carcinoma--update and present management controversies.
September 2006, Annals of the Royal College of Surgeons of England,
Dhakshinamoorthy Ganeshan, and Erik Paulson, and Cihan Duran, and Maria E Cabanillas, and Naifa L Busaidy, and Chusilp Charnsangavej
Medullary thyroid carcinoma: recent advances and management update.
October 1995, Thyroid : official journal of the American Thyroid Association,
Dhakshinamoorthy Ganeshan, and Erik Paulson, and Cihan Duran, and Maria E Cabanillas, and Naifa L Busaidy, and Chusilp Charnsangavej
Update on the cytologic and molecular features of medullary thyroid carcinoma.
January 2014, Advances in anatomic pathology,
Copied contents to your clipboard!